TITLE

Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus

AUTHOR(S)
Biessels, G. J.; De Leeuw, F-E.; Lindeboom, J.; Barkhof, F.; Scheltens, P.
PUB. DATE
March 2006
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Mar2006, Vol. 77 Issue 3, p304
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The risk of Alzheimer's disease (AD) is increased in type 2 diabetes (DM2). This increased risk has been attributed to vascular comorbidity, but other mechanisms, such as accelerated ageing of the brain, have also been implicated. Objective: To determine whether AD in patients with DM2 is associated with an increased occurrence of vascular lesions in the brain, by increased cerebral atrophy, or a combination of both. Methods: In total, 29 patients with AD and DM2 and 58 patients with AD and without DM2 were included in the study. Clinical characteristics were recorded, and a neuropsychological examination and magnetic resonance imaging (MRI) scan were performed. MRI scans were rated for cortical and subcortical atrophy, medial temporal lobe atrophy, white matter lesions, and infarcts. Results: The neuropsychological profiles of the two groups were identical. Patients with AD and DM2 had increased cortical atrophy on MRI (p<0.05) compared with the non-DM2 group. In addition, infarcts were more common (odds ratio 2.4; 95% CI 0.8 to 7.8), but this effect did not account for the increased atrophy. The other MR measures did not differ between the groups. Conclusion: The results suggest that non-vascular mechanisms, leading to increased cortical atrophy, are also involved in the increased risk of AD in DM2.
ACCESSION #
20448038

 

Related Articles

  • Advanced BrainAGE in older adults with type 2 diabetes mellitus. Franke, Katja; Gaser, Christian; Manor, Brad; Novak, Vera // Frontiers in Aging Neuroscience;Nov2013, Vol. 5, p1 

    Aging alters brain structure and function and diabetes mellitus (DM) may accelerate this process. This study investigated the effects of type 2 DM on individual brain aging as well as the relationships between individual brain aging, risk factors and functional measures. To differentiate a...

  • Thalamic resting-state functional connectivity: disruption in patients with type 2 diabetes. Chen, Yu-Chen; Xia, Wenqing; Qian, Cheng; Ding, Jie; Ju, Shenghong; Teng, Gao-Jun // Metabolic Brain Disease;Oct2015, Vol. 30 Issue 5, p1227 

    To explore the disrupted thalamic functional connectivity and its relationships with cognitive dysfunction in type 2 diabetes mellitus (T2DM) by using resting-state functional magnetic resonance imaging (fMRI). A total of 38 T2DM patients and 39 well-matched healthy controls participated in the...

  • Diabetes and AD: Is there a common disease mechanism?  // Geriatrics;Jul94, Vol. 49 Issue 7, p18 

    Reports on the possibility that noninsulin-dependent diabetes mellitus (NIDDM) and Alzheimer's disease may have a common mechanism. Findings of a study on both diseases; Need for further study to determine the clinical usefulness of the findings.

  • Banish the bogeyman.  // New Scientist;11/30/2013, Vol. 220 Issue 2945, p3 

    The article focuses on growing evidence that Alzheimer's is a late state of type 2 diabetes, which comes as a good news as type 2 diabetes can be prevented, alleviated and cured by lifestyle changes.

  • Intrahepatic Lipids Are Predicted by Visceral Adipose Tissue Mass in Healthy Subjects. Thamer, Claus; Machann, Jurgen; Haap, Michael; Stefan, Norbert; Heller, Emanuela; Schnodt, Birgit; Stumvoll, Michael; Claussen, Claus; Fritsche, Andreas; Schick, Fritz; Haring, Hans // Diabetes Care;Nov2004, Vol. 27 Issue 11, p2726 

    Presents a study which analyzed the relationship between body fat distribution and hepatic lipids in healthy individuals at increased risk for type 2 diabetes. Magnetic resonance examinations of various fat depots; Influence of sex on fat depots; Results and discussion; Conclusions.

  • Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes. FEINKOHL, INSA; KELLER, MARKETA; ROBERTSON, CHRISTINE M.; MORLING, JOANNE R.; WILLIAMSON, RACHEL M.; NEE, LISA D.; MCLACHLAN, STELA; SATTAR, NAVEED; WELSH, PAUL; REYNOLDS, REBECCA M.; RUSS, TOM C.; DEARY, IAN J.; STRACHAN, MARK W. J.; PRICE, JACKIE F. // Diabetes Care;Sep2013, Vol. 36 Issue 9, p2779 

    OBJECTIVE--Macrovascular disease may contribute to increased risk of accelerated cognitive d decline in patients with type 2 diabetes. We aimed to determine associations of measures of macrovascular disease with cognitive change in a cognitively healthy older population with type 2 diabetes....

  • Management of Type 2 Diabetes Mellitus in Older Adults. Kyung Soo Kim; Soo Kyung Kim; Kyung Mi Sung; Yong Wook Cho; Seok Won Park // Diabetes & Metabolism Journal;Oct2012, Vol. 36 Issue 5, p336 

    In the near future, the majority of patients with diabetes will be adults aged 65 or older. Unlike young adults with diabetes, elderly diabetic people may be affected by a variety of comorbid conditions such as depression, cognitive impairment, muscle weakness (sarcopenia), falls and fractures,...

  • Clinical Complexity and Mortality in Middle-Aged and Older Adults With Diabetes. Cigolle, Christine T.; Kabeto, Mohammed U.; Lee, Pearl G.; Blaum, Caroline S. // Journals of Gerontology Series A: Biological Sciences & Medical ;Dec2012, Vol. 67 Issue 12, p1313 

    Background. Middle-aged and older adults with diabetes are heterogeneous and may be characterized as belonging to one of three clinical groups: a relatively healthy group, a group having characteristics likely to make diabetes self-management difficult, and a group with poor health status for...

  • Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes. Niefeld, Marlene R.; Braunstein, Joel B.; Wu, Albert W.; Saudek, Christopher D.; Weller, Wendy E.; Anderson, Gerard F. // Diabetes Care;May2003, Vol. 26 Issue 5, p1344 

    OBJECTIVE — To examine the impact of comorbid conditions on preventable hospitalizations among Medicare beneficiaries aged ≥65 years with type 2 diabetes. RESEARCH DESIGN AND METHODS — Data were drawn from the 1999 Medicare Standard Analytic Files, a 5% nationally...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics